Bibliography

A

- Adams, Jad, AIDS: The HIV Myth, New York, 1989.
- "AIDS Now: Is There Going to be a Heterosexual Epidemic?", Channel 4 TV (UK), February 5, 1988.
- Alcabes, P., et al., "Correlates of the Rate of Decline of CD4+ Lymphocytes Among Injection Drug Users Infected with Human Immunodeficiency Virus," American Journal of Epidemiology, 137 (1993), pp. 989-1000.
- Altman, L., "Scientists Display Substantial Gains in AIDS Treatment," New York Times, July 11, 1996.
- Altman, L. K., "New Virus Said to Cause a Condition Like AIDS," New York Times, July 23, 1992.
- "American Boy Died of AIDS 18 Years Ago," Daily Telegraph (UK), October 26, 1987.
- Anand, R., et al., "Non-natural Variants of Human Immunodeficiency Virus Isolated from AIDS Patients with Neurological Disorders," Lancet, ii (1987), pp. 234-238.
- Anderson, D. J., et al., "Effects of Disease Stage and Zidovudine Therapy on the Detection of Human Immunodeficiency Virus Type I in Semen," Journal of the American Medical Association, 267 (1992), pp. 2769-2774.
- Anderson, R. M., and May, R. M., "Epidemiological Parameters of HIV Transmission," Nature (London), 333 (1988), pp. 514-519.
- Anderson, R. M. and May, R. M., "Understanding the AIDS Pandemic," Scientific American, 266 (1992), pp.20-26.
- Anonymous, "Patient Accuses Kaiser," Oakland Tribune, December 1, 1992.
- Ascher, M. S., et al., "Does Drug Use Cause AIDS," Nature, 362 (1993), pp. 103-104.
- Ascher, M. S., et al., "AIDS-associated Kaposi's Sarcoma," Science, 267 (1995), p. 1080.
- Ascher, M. S., et al., "Paradox Remains," Nature, 375 (1995), p. 196.
- Auerbach, D. M., et al., "Clusters of Cases of the Acquired Immune Deficiency Syndrome Patients Linked by Sexual Contact," American Journal of Medicine, 76 (1984) pp. 487-492.

B

- Bacellar, H., et al., "Temporal Trends in the Incidence of HIV-I-related Neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992," Neurology, 44 (1994), pp. 1892-1900.
- Balzarini, J., et al., "Differential Patterns of Intracellular Metabolism of 2',3'-didehydro- 2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, Two Potent Anti-Human Immunodeficiency Virus Compounds," Journal of Biological Chemistry, 264 (1989), pp. 6127-6133.
- Bardach, A. L., The Heretic, Buzz, January/February 1992, pp. 68-73, 90, 92.
- Blattner, W. A., et al., "Epidemiology of Human Lymphotropic Retroviruses: An Overview," Cancer Research, 45 (Supplement) (1985), pp. 4598-4601.
- Blattner, W. A., et al., "HIV Causes AIDS," Science, 241 (1988), pp. 514-515.
- Blattner, W. A., "HIV Epidemiology: Past, Present, and Future," FASEB Journal, 5 (1991), pp. 2340-2348.
- Bregman, D. J., and Langmuir, A. D., "Farr's Law Applied to AIDS Projections," Journal of the American Medical Association, 263 (1990), pp. 50-57.
- Brettle, R. P., "Clinical Features of Drug Use and Drug Use Related to HIV," International Journal of STD & AIDS, 7 (1996), pp. 151-165.
- Briggs, L. H., et al., "Severe Systemic Infections Complicating 'Mainline' Heroine Addiction," Lancet, ii (1967), pp. 1227-1231.
- Brown, S. M., et al., "Immunological Dysfunction in Heroin Addicts," Archives of Internal Medicine, 134 (1974), pp. 1001-1006.
- Brudney, K. and Dobkin, L., "Resurgent Tuberculosis in New York City," American Review of Respiratory Diseases, 144 (1991), pp. 744-749.
- Bryant, H. U., et al., "Effects of Cocaine and Other Drugs of Abuse on Immune Responses," in Cocaine: Pharmacology, Physiology and Clinical Strategies, Lakoski, J. M., Galloway, M. P., and White, F. J., Eds., CRC Press, Boca Raton, Florida, 1992.
- Buchbinder, S. P., et al., "Long-term HIV-I Infection Without Immunologic Progression," AIDS, 8 (1994), pp. 1123-1128.
- Bureau of Justice Statistics, Drugs, Crime, and the Justice System, U.S. Department of Justice, Washington, D.C., 1992.
- Burke, D. S., "Human Immunodeficiency Virus Infections in Teenagers: Seroprevalence Among Applicants for the U.S. Military Service," Journal of the American Medical Association, 263 (1990), pp. 2074-2077.
- Burke et al., New England Journal of Medicine, 319 (1988), pp. 961-964.

C

- Callen, M., Surviving AIDS, Harper Perennial, New York, 1990.
- Cao, Y., et al., "Long-term Survivors of Human Immunodeficiency Virus Type I Infection," New England Journal of Medicine, 332 (1995), pp. 201-208.
- Celum, C. L., et al., Journal of Infectious Diseases, 164 (1991), pp. 656-664.
- Centers for Disease Control, AIDS and HIV Infection Among Health-Care Workers, Vol. 37, April 1988, pp.229-239.
- Centers for Disease Control, "Epidemiological Aspects of the Current Outbreak of Kaposi's Sarcoma and Opportunistic Infections," New England Journal of Medicine, 306 (1982), pp. 248-252.
- Centers for Disease Control, HIV/AIDS Surveillance reports.
- Centers for Disease Control, HIV/AIDS Surveillance, Year-end Edition, U.S. Department of Health and Human Services, Atlanta, Georgia, 1992.
- Centers for Disease Control, "1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults," Morbidity and Mortality Weekly Report, 41 (No. RR17) (1992), pp.1-19.
- Centers for Disease Control, "Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome," Journal of the American Medical Association, 258 (1987), pp. 1143-1154.
- Centers for Disease Control, "The Second 100,000 Cases of Acquired Immunodeficiency Syndrome -- United States, June 1981-December 1991," Morbidity and Mortality Weekly Report, 41 (1992), pp. 28-29.
- Centers for Disease Control, "U.S. HIV and AIDS Cases Reported Through December 1994," HIV/AIDS Surveillance Report, 6 (1994), pp. 1-29.
- Centers for Disease Control, "U.S. HIV and AIDS Cases Reported Through December 1996," HIV/AIDS Surveillance Report, 8 (1996), pp.
- Chernov, H. I., Document on New Drug Application 19-655, Food and Drug Administration, Washington, D.C., 1986.
- Chiu, D., et al., "The Toxicity of Azidothymidine (AZT) on Human and Animal Cells in Culture at Concentrations Used for Antiviral Therapy," Genetica, 95 (1995), pp. 103-109.
- Clark, S. J., et al., "High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-infection," New England Journal of Medicine, 324 (1991), pp. 954- 906.
- "Clever Drug or Is It the Marketing?", Continuum, 3 (1995). p. 2.
- Clinton, W., The National Drug Control Strategy: 1996, The White House, Washington, D.C., 1996.
- Coffin, J., et al., "Human Immunodeficiency Viruses," Science, 232 (1986), p. 697.
- Cohen, J., "Mystery Virus meets the Skeptics," Science, 257 (1992), pp. 1032-1034.
- Cohen, J., Science, 259 (1993), pp. 168-170.
- Cohen, J., "Is a New Virus the Cause of KS?", Science, 266 (1994), pp. 1803-1804.
- Cohen, S. S., "Antiretroviral Therapy for AIDS," New England Journal of Medicine, 317 (1987), p. 629.
- Conner, Steve, "AIDS: Science Stands on Trial," New Scientist, February 12, 1987, pp. 49-58.
- Conner, S., "One Year in Pursuit of the Wrong Virus," New Scientist, 113 (1987), pp. 49-58.
- Cowley, G., "Is a New AIDS Virus Emerging?", Newsweek, July 24, 1992, p. 41.
- Cox, T. C., et al., Drugs and Drug Abuse, Addiction Research Foundation, Toronto, Canada, 1983.
- Crewdson, J., "Studies Hint AIDS Spread Less Severe Than Predicted," Chicago Tribune, June 1, 1987.
- Crewdson, J., "The Great AIDS Quest," Chicago Tribune, November 19, 1989.
- Crewdson, J., "In Gallo Case, Truth Termed a Casualty," Chicago Tribune, January 1, 1995.
- Cullitson, B. J., "Inside the Gallo Probe," Science, 248 (1990), pp. 1494-1498.
- Curran, J. W., et al., "The Epidemiology of AIDS: Current Status and Future Prospects," Science, 229 (1985), pp. 1352-1357.

D

- Daar, E. S., et al., "Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type I Infection," New England Journal of Medicine, 324 (1991), pp. 961-964.
- Darby, S. C., et al., "Mortality Before and After HIV Infection in the Complete UK Population of Hemophiliacs," Nature, 377 (1995), pp. 79-82.
- Darrow, W. W., et al., "Risk Factors for Human Immunodeficiency Virus (HIV) Infections in Homosexual Men," American Journal of Public Health, 77 (1987), pp. 479-483.
- Day, M., "Hype, Hope and HIV," New Scientist, 151(1996), pp. 28-31.
- Des Jarlais, D., et al., "Development of AIDS, HIV Seroconversion, and Potential Cofactors for T4 Cell Loss in a Cohort of Intravenous Drug Users," AIDS, 1 (1987), pp. 105-111.
- Dingell, J., "Shattuck Lecture: Misconduct in Medical Research," New England Journal of Medicine, 328 (1993), p. 1613.
- Dingell, Rep. J., Chairman, Report by the Subcommittee on Oversight and Investigations of the House of Representatives, 1994.
- Dismukes, W. E., et al., "Viral Hepatitis Associated with Illicit Parenteral Use of Drugs," Journal of the American Medical Association, 206 (1968), pp. 1048-1052.
- Donahoe, R. M., et al., "Mechanistic Implications of the Findings that Opiates and Other Drugs of Abuse Moderate T-cell Surface Receptors and Antigenic Markers," Annals of the New York Academy of Sciences, 496 (1987), pp. 711-721.
- Dournon, E., et al., "Effects of Zidovudine in 365 Consecutive Patients with AIDS or AIDS-related Complex," Lancet, ii (1988), pp. 1297-1302.
- Drotman, D. P., et al., "Kaposi's Sarcoma. How Can Epidemiology Help Find the Cause?", Dermatoepidemiology, 13 (1995), pp. 575-582.
- Drug Strategies, Keeping Score: What We Are Getting for Our Federal Drug Control Dollars, Drug Strategies, Washington, D.C., 1995.
- "Drugs Boost," Continuum, 4 (1996), p. 3.
- Dubin, G. and Braffman, M. N., "Zidovudine-induced Hepatoxicity," Annals of Internal Medicine, 110 (1989), pp. 85-86.
- Duesberg, P., Inventing the AIDS Virus, Washington, D.C., 1996.

E

- Ellison, B. J., et al., "HIV as a Surrogate Marker for Drug-use: A Re-analysis of the San Francisco Men's Health Study," Genetica, 95 (1995), pp. 165-171.
- Elwell, L. P., et al., "Antibacterial Activity and Mechanism of Action of 3'-azido-3'- deoxythymidine (BW A509U)," Antimicrobial Agents Chemotherapy, 31 (1987), pp. 274-280.
- Erlichman, J., "Welcoming Some Nice, Easy Profits from AIDS Monopoly," Guardian, October 23, 1987.
- Espinoza, P., et al., "High Prevalence of Infection by Hepatitis B Virus and HIV in Incarcerated French Drug Addicts," Gastroenterologie Clinique et Biologique, 11 (1987), pp. 288-292.
- Evans, A. S., "Does HIV Cause AIDS? An Historical Perspective," Journal of AIDS, 2 (1989), pp. 107-113.

F

- Fineberg, H. V., "The Social Dimensions of AIDS," Scientific American, 259 (1988), pp. 128-134.
- Fogelman, I., et al., "Prevalence and Patterns of Use of Concomitant Medications Among Participants in Three Multicenter Human Immunodeficiency Virus Type I Clinical Trials," Journal of Acquired Immune Deficiency Syndromes, 7 (1994), pp. 1057-1063.
- Freeman, B. A., Burrows Textbook of Microbiology, W. B. Saunders Company, Philadelphia, 1979.
- Freiman, J. P., et al., "Hepatomegaly with Severe Steatosis in HIV-seropositive Patients," AIDS, 7 (1993), pp. 379-385.

G

- Gallo, R. C., "Antigens on HTLV-Infected Cells Recognized by Leukaemia and AIDS Sera are Related to HTLV Viral Glycoprotein," Science, May 11, 1984.
- Gallo, R.C., "Mechanism of Disease Induction by HIV," Journal of AIDS, 3 (1990), pp. 380-389.
- Gallo, R.C., Virus Hunting - AIDS, Cancer, and the Human Retrovirus: A Story of Scientific Discovery, Basic Books, New York, 1991.
- Garbulgia, A. R., et al., "In Vitro Activation of HIV RNA Expression in Peripheral Blood Lymphocytes as a Marker to Predict the Stability of Non-progressor Status in Long-term Survivors," AIDS, 10 (1996), pp. 17-21.
- Garry, R. F., et al., "Documentation of an AIDS Virus Infection in the United States in 1968," Journal of the American Medical Association, 260 (1988), pp. 2085-2087.
- Gavzer, B., "Love Has Helped Keep Me Alive," Parade Magazine, April 16, 1995, pp. 4-6.
- Geller, S. A. and Stimmel, B., "Diagnostic Confusion from Lymphatic Lesions in Heroin Addicts," Internal Medicine, 78 (1973), pp. 703-705.
- Gibbons, J., "Drugs & Us," Gay Times (London), September 1996, pp. 17-37.
- Gilden, Raymond V., "HTLV-III Legend Corrected," Science, April 18, 1986, p. 307.
- Gill, P. S., et al., "Azidothymidine Associated with Bone Marrow Failure in the Acquired Immunodeficiency Syndrome (AIDS)," Annals of Internal Medicine, 107 (1987), pp. 502-505.
- Goedert, J. J., et al., "Amyl Nitrite May Alter T Lymphocytes in Homosexual Men," Lancet, i (1982), pp. 412-416.
- Goedert, J. J., et al., "Risks of Immunodeficiency, AIDS, and Death Related to Purity of Factor VIII Concentrate," Lancet, 344 (1994), pp. 791-792.
- Gorman, C., Time, March 22, 1993, p. 49.
- Gottlieb, M.S., et al., "Pneumocystis Pneumonia - Los Angeles," Centers for Disease Control, Morbidity and Morality Weekly Report, 30 (June 5, 1981), pp. 250-252.
- Goudsmit, J., "Alternative View on AIDS," Lancet, 339 (1992), pp. 1289-1290.
- "Government Congressman Questions Funding for AIDS Research," AIDS Weekly (electronic version), May 22, 1995.
- Graham, N. M. Z., et al., "Effect of Zidovudine and Pneumocystis Carinii Pneumonia Prophylaxis on Progression of HIV-I Infection to AIDS," Lancet, 338 (1991), pp. 265-269.
- Greenblatt, R. M., et al., "Polypharmacy Among Patients Attending an AIDS Clinic: Utilization of Prescribed, Unorthodox, and Investigational Treatments," Journal of Acquired Immune Deficiency Syndromes, 4 (1991), pp. 136-143. H

I

- Institute of Medicine, Confronting AIDS, National Academy Press, Washington, D.C., 1986.
- Institute of Medicine, Confronting AIDS - Update 1988, National Academy Press, Washington, D.C., 1988.

J

- Jackson, T., "Gambling on AIDS Drug Gives Wellcome a Happy Anniversary," Financial Times, February 21, 1987.
- Jaffe, H. W., et. al., "National Case-control Study of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual Men: Part I, Epidemiologic Results," Annals of Internal Medicine, 99 (1983), pp. 145-151.
- Jaffe, H. W., et al., "Acquired Immune Deficiency Syndrome in the United States: The First 1000 Cases," Journal of Infectious Diseases, 148 (1983), pp. 339-345.
- Johnson, C., "Factors Known to Cause False-positive Antibody Test Results," Continuum (London), 4 (1996), p. 5.

K

- Kaslow, R. A., et al., "Infection with Human Immunodeficiency Virus: Clinical Manifestations and Their Relationship to Immunodeficiency," Annals of Internal Medicine e, 107 (1987), pp. 474-480.
- Kolata, G., "Imminent Marketing of AZT Raises Problems: Marrow Suppression Hampers AZT Use in AIDS Victims," Science, 235 (1987), pp. 1462-1463.
- Kolata, G., "After 5 Years of Use, Doubt Still Clouds Leading AIDS drug," New York Times, June 2, 1992.
- Kolata, G., "New Picture of Who Will get AIDS is Dominated by Addicts," New York Times, February 28, 1995.
- Kono, R., "Introductory Review of Subacute Myelo-optico-neuropathy (SMON) and its Studies Done by the SMON Research Committee," Japanese Journal of Medicine, Science and Biology, 28 (Supplement) (1975), pp. 1-21.
- Kozel, N. J., and Adams, E. H., "Epidemiology of Drug Abuse: An Overview," Science, 234 (1986), pp. 970-974.
- Kramer, L., "Checking In, My Chart," POZ, August/September 1994, pp. 92-93.
- Kramer, L., "A Good News/Bad News AIDS Joke," New York Times, July 14, 1996.
- Kreiss, J. K., et al., "Human T Cell Leukemia Virus Type III Antibody, Lymphadenopathy, and Acquired Immune Deficiency Syndrome in Hemophiliac Subjects," American Journal of Medicine, 80 (1986), pp. 345-350.
- Krieger, L., "1 in 300 U.S. Adults Infected, Says Report," San Francisco Examiner, July 7, 1996.

L

- Land, W., et al., "Patterns of T Lymphocyte Changes with Human Immunodeficiency Virus Infection: From Seroconversion to the Development of AIDS," Journal of AIDS, 2 (1989), pp. 63-69.
- Lang, W. et al., "Clinical, Immunologic, and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome," Journal of the American Medical Association, 257 (1987), pp. 326-330.
- Langhof, E., et al., "Most CD+ T-cells from Human Immunodeficiency Virus-I Infected Patients Can Undergo Prolonged Clonal Expansion," Journal of Clinical Investigation, 84 (1989), pp. 1637-1643.
- Larrat, P. E., and Zierler, S., "Entangled Epidemics: Cocaine Use and HIV Disease," Journal of Psychoactive Drugs, 25 (1993), pp. 207-221.
- Laurence, J., et al., "Acquired Immunodeficiency Without Evidence of Infection with Human Immunodeficiency Virus Types I and II," Lancet, 340 (1992), pp. 273-274.
- Lauritsen, J., Poison by Prescription - The AZT Story, Asklepsios Press, New York, 1990.
- Lauritsen, J., "The AIDS War: Censorship and Propaganda Dominate Media Coverage of the Epidemic," New York Native, August 12, 1991.
- Lauritsen, J., "FDA Documents Show Fraud in AZT Trials," New York Native, March 30, 1992.
- Lauritsen, J., AIDS War, Asklepsios (Pagan) Press, New York, 1993.
- Lawrence, D. N., et al., "HIV Transmission from Hemophiliac Men to their Heterosexual Partners," in Heterosexual Transmission of AIDS, Alexander, N. J., Gabelnick, H. L. & Spieler, J. M. (Editors), Wiley-Liss, New York, 1990, pp. 35-53.
- Layon, J., et al., "Altered T-lymphocyte Subsets in Hospitalized Intravenous Drug Abusers," Archives of Internal Medicine, 144 (1984), pp. 1376-1380.
- Learmont, J., et al., "Long-term Symptomless HIV-I Infection in Recipients of Blood Products from a Single Donor," Lancet, 340 (1992), pp. 863-867.
- Leland, J., "The End of AIDS?", Newsweek, December 2, 1996, pp. 64-73.
- Lemp, G. F., et al., "Projections of AIDS Morbidity and Mortality in San Francisco," Journal of the American Medical Association, 263 (1990), pp. 1497-1501.
- Lenderking, W. R., et al., "Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection," New England Journal of Medicine, 330 (1994), pp. 738-743.
- Lerner, W. D., "Cocaine Abuse and Acquired Immunodeficiency Syndrome: Tale of Two Epidemics," American Journal of Medicine, 87 (1989), pp. 661-663.
- Lesbian and Gay Substance Abuse Planning Group, Gay Men, Lesbians, and Their Alcohol and Other Drug Use: A Review of the Literature, San Francisco Department of Public Health, San Francisco, CA, 1991.
- Levy, J., "Mysteries of HIV: Challenges for Therapy and Prevention," Nature, (London) 333 (198), pp. 519-522.
- Louria, D. B., "Infectious Complications of Nonalcoholic Drug Abuse," A. Review of Medicine, 25 (1974), pp. 219-231.

M

- Maddox, J., "Rage and Confusion Hide Role of HIV," Nature, 357 (1992), pp. 188-189.
- Maddox, J., "Where the AIDS Virus Hides Away," Nature, 362 (1993), p. 287.
- Mann, J., et al., "The International Epidemiology of AIDS," Scientific American, 259 (1988), pp. 82-89.
- Mann, J. and Global AIDS Policy Coalition, AIDS in the World, Harvard International AIDS Center, 1992.
- Mansuri, M. M., et al., "Comparison of In Vitro Biological Properties and Mouse Toxicities of Three Thymidine Analogs Active Against Human Immunodeficiency Virus," Antimicrobial Agents in Chemotherapy, 34 (1990), pp. 637-641.
- Marion, S. A., et al., "Evidence That Prior Immune Dysfunction Predisposes to Human Immunodeficiency Virus Infection in Homosexual Men," Journal of AIDS, 2 (1989), pp. 178-186.
- Marmor, M. A., et al., "Risk Factors for Kaposi's Sarcoma in Homosexual Men," Lancet, i (1982), pp. 1083-1087.
- Mathur-Wagh, U., et al., "Longitudinal Study of Persistent Generalized Lymphadenopathy in Homosexual Men: Relation to Acquired Immunodeficiency Syndrome," Lancet, i (1984), pp. 1033-1038.
- Mazzitelli, T., "AIDS Profits Take Off 'Like Any Other Business'," Gemini News Service, November 20, 1987.
- McDonough, R. J., et al., "Alteration of T and Null Lymphocyte Frequencies in the Peripheral Blood of Human Opiate Addicts: In Vivo Evidence of Opiate Receptor Sites on T Lymphocytes," Journal of Immunology, 125 (1980), pp. 2539-2543.
- McLeod, G. X. and Hammer, S. M., "Zidovudine: Five Years Later," Annals of Internal Medicine, 117 (1992), pp. 487-501.
- Mir, N. and Costello, C., "Ziduvodine and Bone Marrow," Lancet, ii (1988), pp. 1195-1995.
- Montefiori, D. C., et al., "Neutralizing and Infection-enhancing Antibody Responses to Human Immunodeficiency Virus Type I in Long-term Nonprogressors," Journal of Infectious Diseases, 173 (1996), pp. 60-67.
- Moore, J. D., et al., "HTLV-III Seropositivity In 1971-1972 Parental Drug Abusers - A Case of False Positives or Evidence of Viral Exposure?", New England Journal of Medicine, 314 (1986), pp. 1387-1388.
- Moore, P. S. and Chang, Y., "Detection of Herpes-like DNA Sequences in Kaposi's Sarcoma in Patients with and Those Without HIV Infection," New England Journal of Medicine, 332 (1995), pp. 1181-1185.
- Morgan, M., et al., "The Future Course of AIDS in the United States," Journal of the American Medical Association, 263 (1990), pp. 1539-1540.
- Moss, A. R., "AIDS and Intravenous Drug Use: The Real Heterosexual Epidemic," British Medical Journal, 294 (1987), pp. 389-390.
- Moss, A. R., et al., "The Cause of AIDS," Science, 242 (1988), p. 997.
- Munoz, A., "Disease Progression 15 Percent of HIV-infected Men Will Be Long-term Survivors," AIDS Weekly, News Report, May 15 and May 29, 1995.
- Munoz, A., et al., "Long-term Survivors with HIV-I Infection: Incubation Period and Longitudinal Patterns of CD4+ Lymphocytes," Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8 (1995), pp. 496-505.

N

- National Commission on AIDS, The Twin Epidemics of Substance Abuse and HIV, July 1991.
- Newell, G. R., et al., "Volatile Nitrites: Use and Adverse Effects Related to the Current Epidemic of the Acquired Immune Deficiency Syndrome," American Journal of Medicine, 78 (1985), pp. 811-816.
- Newell, G. R., et al., "Risk Factor Analysis Among Men Referred for Possible Acquired Immune Deficiency Syndrome," Preventive Medicine, 14 (1985), pp. 81-91.
- Nicholson, J., "Rebel Scientists: HIV Doesn't Cause AIDS," New York Post, July 23, 1992.
- Novick, D. M., et al., "Natural Killer Cell Activity and Lymphocyte Subsets in Parenteral Heroine Abusers and Long-term Methadone Maintenance Patients," The Journal of Pharmacology and Experimental Therapeutics, 250 (1989), pp. 606-610.
- Nussbaum, B., Good Intentions: How Big Business, Politics, and Medicine are Corrupting The Fight Against AIDS, Atlantic Monthly Press, 1990.

O

- Ostrow, D. G., et al., "Recreational Drug Use and Sexual Behavior Change in a Cohort of Homosexual Men," AIDS, 4 (1990), pp. 759-765.
- Ostrow, D. G., et al., "Recreational Drugs and Sexual Behavior in the Chicago MACS/CCS Cohort of Homosexually Active Men," Journal of Substance Abuse, 5 (1993), pp. 311-325.

P

- Pantaleo, G., et al., "Studies in Subjects with Long-term Nonprogressive Human Immunodeficiency Virus Infection," New England Journal of Medicine, 332 (1995), pp. 209-216.
- Papdopulos-Eleopulos, E., et al., "Is a Positive Western Blot Proof of HIV Infection?", Biotechnology, 11 (1993), pp. 696-707.
- Parker, W. B. and Cheng, Y. C., "Mitochondrial Toxicity of Antiviral Nucleoside Analogs," Journal of National Institutes of Health Research, 6 (1994), pp. 57-61.
- Phair, J., et al., Journal of AIDS, 5 (1992), pp. 5988-5992.
- Physician's Desk Reference, Medical Economics Company, New Jersey, 1994.
- Piatek, M. et al., "High Levels of HIV-I in Plasma During All Stages of Infection Determined by Competitive PCR," Science, 259 (1993), pp. 1749-1754.
- Pillai, R., et al., "AIDS, Drug Abuse and the Immune System: A Complex Immunotoxilogical Network," Archives of Toxicology, 65 (1991), pp. 609-617.
- Pillari, G. and Narus, J., "Physical Effects of Heroine Addiction," American Journal of Nursing, 73 (1973), pp. 2105-2109.
- Pluda, J. M., et al., "Development of Non-Hodgkin Lymphoma in a Cohort of Patients with Severe Human Immunodeficiency Virus (HIV) Infection on Long-term Antiretroviral Therapy," Annals of Internal Medicine, 113 (1990), pp. 276-282.
- Poznansky, M. C., et al., "HIV Positive Patients First Presenting with an AIDS Defining Illness: Characteristics and Survival," British Medical Journal, 311 (1995), pp. 156-158.
- Project Inform, Is HIV the Cause of AIDS?, Project Discussion Paper #5, San Francisco, May 27, 1992.

R

- Rappaport, J., AIDS INC., Human Energy Press, San Bruno, CA, 1988.
- Rasnick, D., "Inhibitors of HIV Protease Useless Against AIDS Because HIV Doesn't Cause AIDS," Reappraising AIDS, 4 (1996), pp. 1-4.
- Raymond, C. A., "Combating a Deadly Combination: Intravenous Drug Abuse, Acquired Immunodeficiency Syndrome," New England Journal of Medicine, 259 (1988), pp. 329-332.
- Reitz, M.S. and Streicher, H. Z., "Gallo's Virus Sequence," Nature, 351 (1991), p. 358.
- "Retrovir," Physicians' Desk Reference, Medical Economics Company, New Jersey, 1994.
- Richman, D. D., et al., "The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-related Complex," New England Journal of Medicine, 317 (1987), pp. 192-197.
- Root-Bernstein, R. S., "Five Myths About AIDS that Have Misdirected Research and Treatment," Genetica, 95 (1995), pp. 111-132.
- Rotello, G., "A Deal with the Devil," The Advocate, October 1996, p. 15.
- Rubenstein, E., "The Untold Story of HUT78," Science, 248 (1990), pp. 1499-1507.

S

- Saah, A. J., et al., "Predictors for Failure of Pneumocystis Carinii Pneumonia Prophylaxis," Journal of the American Medical Association, 273 (1995), pp. 1197-1202.
- Sadownick, D., "Kneeling at the Crystal Cathedral," Genre, December/January 1994, pp. 40-45, 86-90.
- Safai, B., et al., "Kaposi's Sarcoma among HIV-negative High Risk Population," VII International Conference on AIDS, 1991.
- Salahuddin, S. K., et al., "Angiogenic Properties of Kaposi's Sarcoma-derived Cells After Long-term Culture In Vitro," Science, 242 (1988), pp. 430-433.
- Sapira, J. D., "The Narcotic Addict as a Medical Patient," American Journal of Medicine, 45 (1968), pp. 555-588.
- Savona, S., et al., "Thrombocytopenic Purpura in Narcotics Addicts," Internal Medicine, 102 (1985), pp. 737-741.
- Schechter, M. T., et al., "Aetiology of AIDS," Lancet, 341 (1993), pp. 1222-1223.
- Schnittman, S. M., et al., "The Reservoir for HIV-I in Human Peripheral Blood is a T Cell that Maintains Expression of CD4," Science, 245 (1989), pp. 305-308.
- Schuster, C. R., "Foreward," in Cocaine: Pharmacology, Effects and Treatment of Abuse, J. Grabowski, Editor, National Institute on Drug Abuse, Washington, D.C., 1984, pp. vii-vii.
- Scolaro, M., et al., "Potential Molecular Competition for HIV," Lancet, 337 (1991), pp. 731-732.
- Seligmann, M., et al., "AIDS - An Immunologic Reevaluation," New England Journal of Medicine, 311 (1984), pp. 1286-1292.
- Seligmann, M., et al., "Concorde: MRC/ANRS Randomized Double-blind Controlled Trial of Immediate and Deferred Zidovudine in Symptom-free HIV Infection," Lancet, 33 (1994), pp. 871-881.
- Selik, R. M., et al., "Impact of the 1987 Revision of the Case Definition of Acquired Immune Deficiency Syndrome in the United States," Journal of AIDS, 3 (1990), pp. 73-82.
- Selwyn, P. A., et al., "Impact of the AIDS Epidemic on Morbidity and Mortality Among Intravenous Drug Users in a New York City Methadone Maintenance Program," American Journal of Public Health, 79 (1989), pp.1358-1362.
- Shigematsu, I., et al., "Epidemiological Approach to SMON (Subacute Myelo-optico- neuropathy)," Japanese Journal of Medicine, Science and Biology, 28 (Supplement) (1975), pp. 23-33.
- Simmonds, P., et al., "Human Immunodeficiency Virus-infected Individuals Contain Provirus in Small Numbers of Peripheral Mononuclear Cells and at Low Copy Numbers," Journal of Virology, 64 (1990), pp. 864-872.
- Smothers, K., "Pharmacology and Toxicology of AIDS Therapies," The AIDS Reader, I (1991), pp. 29-35.
- Spira, T. J. and Jones, B. M., "Is There Another Agent That Causes Low CD4 Counts and AIDS?", Journal of Cellular Biochemistry, (Supplement) 16E (1992), p. 56.
- Steinbrook, R., "Scientists Infect Monkeys with Human AIDS Virus," Los Angeles Times, June 12, 1992.
- Stolberg, S., "AIDS Tally to Increase Due to New Definition," Los Angeles Times, December 31, 1992.
- Stoneburner, R. L., et al., "A Large Spectrum of Severe HIV-I-related Disease in Intravenous Drug Users in New York City," Science, 242 (1988), pp. 916-919.
- Swanson, C. E., et al., "Factors Influencing Outcome of Treatment with Zidovudine of Patients with AIDS in Australia," AIDS, 4 (1990), pp. 749-757.

T

- Tanaka, M., "Abrams Cautious on Use of New AIDS Drug," Synapse, 41 (1996), pp. 1, 5.
- Terry, C. E., and Pellens, E., The Opium Problem, Bureau of Social Hygiene of New York, 1928.
- The Merck Manual, New Jersey, 1996-97, Section 18, Item 247.
- The Relationship Between Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome, National Institute for Allergy & Infectious Diseases, Maryland, 1996.
- Till, M. and MacDonnell, K. B., "Myopathy with Human Immunodeficiency Virus Type I (HIV-I) Infection: HIV-I or Zidovudine?", Annals of Internal Medicine, 113 (1990), pp. 492-494.
- Tuller, D., "Uncertain Life After Certain Death," San Francisco Chronicle, November 24, 1996.
- Turner, C. F., et al., AIDS, Sexual Behavior and Intravenous Drug Use, National Academy Press, Washington, D.C., 1989.

U

- Unsigned article, "Why the AIDS Virus is Not Like HTLVs I or II," New Scientist, February 7, 1985, p. 4.
- Unsigned article, "Revised Case Definition of AIDS," British Medical Journal, October 31, 1987, p. 1125.
- Unsigned editorial, "Defending the Indefensible Dr. Gallo," Chicago Tribune, January 6, 1995.
- U.S. Department of Health and Human Services, "Annual Emergency Department Data 1993," Data from the Drug Abuse Warning Network (DAWN), 1993, pp. 81-110.
- U.S. Department of Health and Human Services, "Annual Medical Examiner Data," Data from the Drug Abuse Warning Network (DAWN), 1994, pp. 1-82.

V

- Valentine, C. B., et al., "Anonymous Questionnaire to Assess Consumption of Prescribed and Alternative Medication and Patterns of Recreational Drug Use in a HIV Population." AIDS Weekly, August 10, 1992, p. 18.
- van Griensven, G. J. P., et al., "Risk Factors for Progression of Human Immunodeficiency Virus (HIV) Infection Among Seroconverted and Seropositive Homosexual Men," American Journal of Epidemiology, 132 (1990), pp. 203-210.
- van Leeuwen, R., et al., "Failure to Maintain High-Dose Treatment Regimens During Long-term Use of Zidovudine in Patients with Symptomatic Human Immunodeficiency Virus Type I Infection," Genitourin Medicine, 66 (1990), pp. 418-422.
- van Voorhis, B. J., et al., "Detection of Human Immunodeficiency Virus Type I in Semen from Seropositive Men Using Culture and Polymerase Chain Reaction Deoxyribonucleic Acid Amplification Techniques," Fertility/Sterility, 55 (1991), pp. 588-594.
- Vermund, S., "Changing Estimates of HIV-I Seroprevalence in the United States," Journal of National Institutes of Health Research, 3 (1991), pp. 77-81.
- Volberding, P. A., et al., "Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer than 500 CD4-positive Cells per Cubic Millimeter," New England Journal of Medicine, 322 (1990), pp. 941-949.
- Volberding, P. A., et al., "A Comparison of Immediate with Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter," New England Journal of Medicine, 333 (1995), pp. 401-407.

W

- Wain-Hobson, S., "Virological Mayhem," Nature, 373 (1995), p. 102.
- Walker, C. M., et al., "CD8+ Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication," Science, 234 (1986), pp. 1563-1566.
- Walker, R. E., et al., "Anemia and Erythropoiesis in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and Kaposi Sarcoma Treated with Zidovudine," Annals of Internal Medicine, 108 (1988), pp. 372-376.
- Weber, R., et al., "Progression of HIV Infection in Misusers of Injected Drugs Who Stop Injecting or Follow a Programme of Maintenance Treatment with Methadone," British Medical Journal, 301 (1990), pp. 1362-1365.
- Weisberg, M. S., "AIDS: The New Money-Maker," Daily News, New York, August 18, 1987.
- Weiss, R. A., "A Virus in Search of a Disease," Nature (London), 349 (1988), pp. 497-498.
- Weiss, R. and Jaffe, H., "Duesberg, HIV and AIDS," Nature (London), 345 (1990), pp. 659-660.
- Weiss, R., Nature, 349 (1991), p. 374
- Weiss, S. H., "Links between Cocaine and Retroviral Infection," Journal of the American Medical Association, 261 (1989), pp. 607-609.
- Weiss, S. H., et al., "Idiopathic CD4+ T-lymphocytopenia," Lancet, 340 (1992), pp. 608-609.
- Wells, J., "We Have to Question the So-called 'Facts'," Capitol Gay, August 20, 1993, pp. 14-15.
- Wesson, D. and Smith, D., "Cocaine: Treatment Perspectives," in Cocaine Use in America: Epidemiological and Clinical Perspectives, N. Kozel and E. Adams, Eds., MIDA US Department of Health and Human Services, Washington, D.C., 1985.
- Winkelstein, W., Jr., et al., "Sexual Practices and Risk of Infection by the Human Immunodeficiency Virus: The San Francisco Men's Health Study," Journal of the American Medical Association, 257 (1987), pp. 321-325.
- Wyatt, E. A., "Rushing to Judgment," Barron's, August 15, 1994, pp. 23-27.

Y

- Yarchoan, R. and Broder, S., "Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related Disorders," New England Journal of Medicine, 316 (1987), pp. 557-564.
- Yarchoan, R. and Broder, S., "Antiretroviral Therapy for AIDS," New England Journal of Medicine, 317 (1987), p. 630.
- Yarchoan, R., et al., "Antiretroviral Therapy of Human Immunodeficiency Virus Infection: Current Strategies and Challenges for the Future," Blood, 78 (1991), pp. 859-884.